Campeche, Aguascalientes Secure MX$480M for Public Health

Mexico's Ministry of Health increased federal public health subsidies for Campeche and Aguascalientes to a combined MX$479.97 million for 2026, redirecting resources toward dengue control, universal vaccination, and epidemiological surveillance. The adjustment reflects ongoing federal-state health coordination within a broader financing squeeze, as Mexico's 2026 national health budget rose 5.9% while remaining below WHO investment benchmarks. Pharmaceutical distributors, vaccine suppliers, and health service providers operating in both states gain visibility into near-term institutional demand tied to these federally funded programs. 

The Ministry of Health updated federal public health funding agreements with Campeche and Aguascalientes, publishing two modified agreements in the Official Gazette of the Federation (DOF) on Aug. 31, 2026. Combined, the instruments set maximum federal allocations of MX$479.97 million (US$28.20 million) for programs covering dengue, universal vaccination, epidemiological surveillance, sexual and reproductive health, HIV, and cancer prevention.

The updates do not create new programs and do not confirm that the full amount has been exercised. Both agreements adjust the budgetary resources and annexes governing how the federal government transfers funds and supplies to state health authorities. The publications follow a pattern established earlier in 2026, when the Ministry of Health signed a similar amendment allocating MX$500 million in federal health resources to Mexico City, also directing the largest share toward universal vaccination. As with that agreement, the federal resources carry the legal status of subsidies tied to compliance with wellbeing indicators, goals, and program parameters, rather than open-ended transfers.

The instruments arrive as Mexico works through a broader financing squeeze in its public health system. The 2026 federal health budget rose 5.9% to MX$965 billion, driven mainly by increases for the Mexican Social Security Institute (IMSS) and IMSS-Bienestar, though analysts say investment remains below World Health Organization recommendations relative to population needs. State-level coordination agreements such as those for Campeche and Aguascalientes represent one of the mechanisms through which that federal budget reaches subnational health systems for disease prevention and primary care programs. The documents can be consulted directly through the DOF publications for Campeche and Aguascalientes.

The dengue allocations for both states come as national case figures show improvement. The Ministry of Health reported declines in dengue, COVID-19, and measles cases during 2026, crediting expanded vaccination campaigns and sustained epidemiological surveillance carried out jointly by federal, state, and municipal authorities. Officials continue to identify the elimination of mosquito breeding sites as the most effective preventive measure against dengue, a priority reflected in the vector-control funding built into both state agreements.

Campeche Concentrates the Larger Allocation

The Campeche agreement sets a maximum of MX$364.31 million (US$21.40 million), composed of MX$262.58 million in federal budgetary resources and MX$101.73 million in federal supplies. Vector-borne disease programs account for a significant share of the total. The dengue program alone registers MX$144.20 million, split between MX$123.29 million in budgetary resources and MX$20.92 million in supplies. Universal Vaccination follows with MX$69.62 million in federal supplies, while laboratory-based epidemiological surveillance receives MX$63.79 million, almost entirely through budgetary resources.

Additional allocations for Campeche include MX$18.87 million for sexual and reproductive health, covering maternal and perinatal care, family planning, adolescent care, and gender violence prevention, as well as MX$4.49 million for cancer prevention and control, MX$9.43 million for HIV and other sexually transmitted infections, and MX$5.05 million for cardiometabolic diseases. Remaining funds cover health emergencies, mycobacteriosis, chronic respiratory diseases, aging-related care, and oral health.

Vaccination Drives the Aguascalientes Allocation

The Aguascalientes agreement sets a maximum of MX$115.65 million (US$6.79 million), composed of MX$37.43 million in federal budgetary resources and MX$78.23 million in supplies. Universal Vaccination represents the largest single line item at MX$60.97 million in federal supplies, more than half the state total, reflecting a different funding profile from Campeche, where dengue and surveillance carry more weight.

Other allocations for Aguascalientes include MX$8.05 million for dengue, MX$6.74 million for cardiometabolic diseases, MX$6.49 million for maternal health, MX$6.17 million for cancer prevention and control, and MX$3.93 million for HIV and other sexually transmitted infections.

The Aguascalientes agreement additionally incorporates a new Annex 6 to track supplies and goods received through donations, supplier-provided benefits, and the Health Fund for Wellbeing (FONSABI). The agreement specifies that these goods are not classified as federal resources transferred under the instrument itself; their inclusion is intended for tracking and evaluation purposes rather than budgetary accounting.

Both agreements took effect on the date of signature and assign responsibility to each state's executing health authority for administering, verifying, and reporting on the use of federal resources and supplies, in line with the oversight terms established in the original 2026 coordination agreements. For medical suppliers, distributors, and organizations operating state-level public health programs, the updated allocations offer visibility into near-term institutional demand for vaccines, dengue-control supplies, and maternal and chronic disease treatments across both states for the remainder of the fiscal year.

Any federal budgetary resources left unspent by Dec. 31, 2026 must be returned to the Federal Treasury (TESOFE), consistent with the terms applied to other 2026 state health coordination agreements.